From the *Research and Development Division, Tella Inc, Tokyo; †Research Institute of Pharmaceutical Sciences, Musashino University, Tokyo; ‡Seren Clinic, Tokyo; §Department of Molecular Pathology, Tohoku University School of Medicine, Sendai; ∥R&D Laboratory for Innovative Biotherapeutics, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka; ¶Cell Processing Center, Shinshu University Hospital, Nagano; and #Division of Gastroenterology and Hepatology, Department of Internal Medicine and **Department of Oncology, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Received for publication November 5, 2010; accepted May 9, 2011.
Reprints: Masato Okamoto, DDS, PhD, Research Institute of Pharmaceutical Sciences, Musashino University, 1-1-20 Shinmachi, Nishi-tokyo-shi, Tokyo, 202-8585, Japan (e-mail: [email protected]).
This investigation was supported by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the Foundation for Promotion of Cancer Research; and the Mitsui Life Social Welfare Foundation.
The authors declare no conflict of interest.
